Lung cancer CT screening: is annual screening necessary?

Affiliations

¹ Roy Castle Lung Cancer Research Programme, University of Liverpool, The Apex Building, Liverpool L7 8TX, UK. Electronic address: j.k.field@liv.ac.uk.
² Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Comment

John K Field et al. Lancet Oncol. 2016 May.

. 2016 May;17(5):543-4.

doi: 10.1016/S1470-2045(16)00079-6. Epub 2016 Mar 18.

¹ Roy Castle Lung Cancer Research Programme, University of Liverpool, The Apex Building, Liverpool L7 8TX, UK. Electronic address: j.k.field@liv.ac.uk.
² Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

No abstract available

Comment on

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF Jr, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR. Patz EF Jr, et al. Lancet Oncol. 2016 May;17(5):590-9. doi: 10.1016/S1470-2045(15)00621-X. Epub 2016 Mar 18. Lancet Oncol. 2016. PMID: 27009070 Free PMC article. Clinical Trial.